HOME >> BIOLOGY >> NEWS
Nanotechnology's progress and challenges addressed during ACS meeting

EACH PAPER EMBARGOED FOR RELEASE UNTIL DATE AND TIME OF PRESENTATION UNLESS NOTED OTHERWISE

SAN DIEGO From promising diagnostic tests to tomorrow's electronics, nanotechnology the science and technology of the ultra-small is getting bigger all the time. More than 60 presentations, in symposia ranging from medicine to the environment to business, highlight nanotechnology's progress and challenges during the 229th national meeting of the American Chemical Society, the world's largest scientific society, in San Diego, March 13-17. Highlights from selected symposia and research presentations are highlighted below:

Monday, March 14

How do you name a nanomaterial?When the field of molecular genetics emerged, scientists often found themselves calling a new gene by different names. Nanotechnology researchers now face a similar challenge. What's more, this name game has regulatory importance: Today, the government evaluates and regulates the toxicity of a named chemical entity without considering different-sized versions of it. But nanoparticles bear unique electronic and mechanical features. Now, to clear up these concerns and more, a researcher at Rice University is leading the call to build a nomenclature for nanotechnology. (IEC 116, Monday, March 14, 4:00 p.m., Hyatt Regency, Room Ford A, during the symposium "Nanotechnology and the Environment.")

Growing the business of nanotechnology Since nanotechnology emerged, dozens of businesses in California have launched big dreams for tiny tools. Illustrating this boom is Nanosys, launched in 2002 in Palo Alto, Calif. Nanosys has built early versions of nano-enabled solar cells, flexible electronics, and nano chips for drug discovery research. Along the way, the company has formed strategic relationships with industry giants such as Intel, Dupont, In-Q-Tel, SAIC, Sharp, and Matsushita. T
'"/>


17-Mar-2005


Page: 1 2 3

Related biology news :

1. Nanotechnologys past, present and future: A Congressional perspective
2. Study begins to reveal clues to the cause and progression of sepsis
3. ACMG recognizes progress made in newborn screening
4. Neuroblastoma expert reviews progress and challenges in fighting difficult pediatric cancer
5. Scripps research scientists show protein accelerates breast cancer progression in animal models
6. Inflammation is at the origin and progression of diseases such as diabetes or cancer
7. Los Alamos National Laboratory making progress in Groundwater Protection Program
8. Crucial progress in understanding Fragile X mental retardation protein
9. Yin and yang -- Balance could play key role in progression of Alzheimers disease
10. Cancer scientists create human leukemia process to map how disease begins, progresses
11. Treatment-induced growth factor causes cancer progression

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/4/2017)... , Oct. 4, 2017  GCE Solutions, a global clinical research ... and document anonymization solution on October 4, 2017. Shadow is designed ... to comply with policy 0070 of the European Medicines Agency (EMA) ... ... Solutions ...
(Date:8/15/2017)... --  ivWatch LLC , a medical device company focused on improving ... of its ISO 13485 Certification, the global standard for medical device ... (ISO®). ... Monitoring device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it ...
(Date:6/30/2017)... June 30, 2017 Today, American Trucking ... supplier of face and eye tracking software, became ... provider program. "Artificial intelligence and ... to monitor a driver,s attentiveness levels while on ... able to detect fatigue and prevent potential accidents, ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh ... orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of ... SBT-100 is able to cross the cell membrane and bind intracellular STAT3 and ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the ... for Excellence in Volunteer Experience from US2020. , US2020’s mission is to change ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology:
Cached News: